Irofulven

This classification denotes an antineoplastic alkylating agent with the molecular formula C15H18O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6B799IH05A, chemically known as spiro(cyclopropane-1,5(5h)-inden)-7(6h)-one, 6-hydroxy-3-(hydroxymethyl)-2,4,6-trimethyl-, (r)- but more generally known as irofulven, which bears U.S. National Institutes of Health Compound Identifier 148189. European Medicines Agency schedules Irofulven in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02773MIG. The term IROFULVEN is an International Non-Proprietary Name. Most nations schedule irofulven under HS 29144090 and SITC 51629. As of Q4 2014, IROFULVEN remains the US FDA Preferred Term for this commodity. Irofulven bears US NLM identifiers UMLS ID C0532362 and NCI Concept Code C1717. SMILES: OC1(C2(CC2)C(=C2C(=CC(=C2CO)C)C1=O)C)C.